Interleukin‐10‐induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes

IL‐10 is a potent anti‐inflammatory cytokine interfering with antigen presentation by inducing the intracellular sequestration of MHC class II (MHC‐II) molecules. Here we studied the contribution of membrane‐associated RING‐CH (MARCH) ubiquitin ligase family members to the IL‐10‐induced down‐regulation of MHC‐II molecules. We found that MARCH1 and MARCH8 proteins are the most potent family members for the down‐regulation of MHC‐II surface expression in transfected cells, but only MARCH1 mRNA expression is strongly induced by IL‐10 in human primary monocytes. We detected mono‐ and poly‐ubiquitinated forms of MHC‐II molecules both in IL‐10‐treated monocytes and in cells transfected with MARCH1. We also show direct interaction between MHC‐II and MARCH1 molecules in co‐immunoprecipitation assays. Finally, we found that siRNA‐mediated knockdown of MARCH1 reverses IL‐10‐induced MHC‐II down‐regulation in primary monocytes. Thus, the immunosuppressive effect of IL‐10 on antigen presentation is mediated through induced expression of MARCH1.

[1]  Nadia Catalan,et al.  MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation , 2008, Proceedings of the National Academy of Sciences.

[2]  O. Ohara,et al.  Novel regulation of MHC class II function in B cells , 2007, The EMBO journal.

[3]  C. Melief,et al.  Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. , 2006, Immunity.

[4]  I. Mellman,et al.  Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination , 2006, Nature.

[5]  H. Hotta,et al.  Inhibition of MHC class II expression and immune responses by c-MIR , 2006, The Journal of Immunology.

[6]  H. Hotta,et al.  A novel family of membrane-bound E3 ubiquitin ligases. , 2006, Journal of biochemistry.

[7]  P. Lehner,et al.  Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases , 2005, Immunological reviews.

[8]  W. Reith,et al.  Mini‐review: Specificity and expression of CIITA, the master regulator of MHC class II genes , 2004, European journal of immunology.

[9]  K. Früh,et al.  Downregulation of Major Histocompatibility Complex Class I by Human Ubiquitin Ligases Related to Viral Immune Evasion Proteins , 2004, Journal of Virology.

[10]  R. Sékaly,et al.  The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal. , 2003, International immunology.

[11]  M. Nagano-Fujii,et al.  c-MIR, a Human E3 Ubiquitin Ligase, Is a Functional Homolog of Herpesvirus Proteins MIR1 and MIR2 and Has Similar Activity* , 2003, The Journal of Biological Chemistry.

[12]  S. Emr,et al.  Receptor downregulation and multivesicular-body sorting , 2002, Nature Reviews Molecular Cell Biology.

[13]  W. Reith,et al.  Maturation of Dendritic Cells Is Accompanied by Rapid Transcriptional Silencing of Class II Transactivator (Ciita) Expression , 2001, The Journal of experimental medicine.

[14]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[15]  W. Reith,et al.  CIITA Leucine-Rich Repeats Control Nuclear Localization, In Vivo Recruitment to the Major Histocompatibility Complex (MHC) Class II Enhanceosome, and MHC Class II Gene Transactivation , 2000, Molecular and Cellular Biology.

[16]  J. Neefjes,et al.  Interleukin-10 Down-Regulates MHC Class II αβ Peptide Complexes at the Plasma Membrane of Monocytes by Affecting Arrival and Recycling , 1997 .

[17]  Antonio Lanzavecchia,et al.  Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells , 1997, Nature.

[18]  R. Steinman,et al.  Developmental regulation of MHC class II transport in mouse dendritic cells , 1997, Nature.

[19]  R. de Waal Malefyt,et al.  Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. , 1997, Immunity.

[20]  M. Goldman,et al.  Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes , 1994, European journal of immunology.

[21]  B. Mach,et al.  Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) , 1993, Cell.

[22]  P. Cresswell,et al.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding , 1990, Nature.